June 26 (Reuters) - Cleo Diagnostics Ltd (COV) :
- COMMENCES U.S. REGULATORY PROCESS WITH FDA
- COMPLETED AN INITIAL PRE-SUBMISSION MEETING WITH FDA
- OUTLINED ITS SUBMISSION FRAMEWORK AND CLINICAL PLAN FOR ITS OVARIAN CANCER DETECTION BLOOD TEST WITH FDA
(([email protected];))
June 26 (Reuters) - Cleo Diagnostics Ltd (COV) : COMMENCES U.S....
Add to My Watchlist
What is My Watchlist?